Clinical Trial: Prospective Study on Exemption of Tumor Bed Boost Radiotherapy for pCR Patients After Breast Conserving Surgery With Neoadjuvant Therapy

U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07113613) titled 'Prospective Study on Exemption of Tumor Bed Boost Radiotherapy for pCR Patients After Breast Conserving Surgery With Neoadjuvant Therapy' on Aug. 06.

Brief Summary: This study is a multicenter, single-arm, phase II clinical trial, aiming to evaluate the safety and efficacy of tumor bed dose escalation radiotherapy for patients with primary breast lesions achieving pCR (ypT0) after neoadjuvant chemotherapy and breast-conserving surgery.

Study Start Date: Jan. 01

Study Type: INTERVENTIONAL

Condition: Breast Cancer

Intervention: RADIATION: Exemption from additional radiotherapy on the tumor bed after surgery

For patients who met...